North America Glucose Monitoring Devices Market Forecast to 2030

North America Glucose Monitoring Devices Market Forecast to 2030 – Regional Analysis – By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)

Send Enquiry
Item ID: BMIRE00029122 Category: Tags: , ,

$2,485$3,885

Description

The North America glucose monitoring devices market is expected to grow from US$ 5,987.78 million in 2022 to US$ 14,409.58 million by 2030. It is estimated to grow at a CAGR of 11.6% from 2022 to 2030.

Rapid Technological Advancements in Glucose Monitoring Devices Fuel North America Glucose Monitoring Devices Market

Products with advanced technologies offer more effective benefits in diabetes treatment. As the prevalence of diabetes increases worldwide, the demand for more products with advancements also accelerates. Thus, researchers have been carrying out research activities resulting in product innovations over the years. There are many methods to deliver insulin into the body, such as needles, insulin pens, and insulin pumps. Insulin pumps are small, computerized diabetes management devices connected with a cannula under the skin to deliver a slow, continuous insulin level. The individual can control the program depending on the requirements. Optimal diabetes management depends on accurate glucose monitoring devices. The increasing advancements in glucose monitoring devices have resulted in smaller required blood volumes with improved accuracy. The ability to transfer data between the blood glucose meter and glucose monitoring devices has also been improved. The increasing advancements in blood glucose monitoring technology have improved accuracy, smaller required blood volumes, and the ability to transfer data between the blood glucose meter and glucose monitoring devices. In June 2022, Abbott announced a new bio wearable that continuously monitors glucose and ketone levels in one sensor. Thus, the technological advancements coupled with the increasing influx of new products are expected to propel the market growth over the forecast years.

North America Glucose Monitoring Devices Market Overview

The North America North America glucose monitoring devices market has been segmented into the US, Canada, and Mexico. The market growth in this region is attributed to the rising diabetic prevalence, and increasing geriatric population are main factors positively influencing the growth of the market. Additionally, technological advancements in monitoring devices further enhances the overall market growth during 2022-2030.

North America Glucose Monitoring Devices Market Revenue and Forecast to 2030 (US$ Million)

North America Glucose Monitoring Devices Market Segmentation

The North America glucose monitoring devices market is segmented into type, application, testing site, end- user, and country.

Based on type, the North America glucose monitoring devices market is segmented into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on application, the North America glucose monitoring devices market is segmented into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on testing site, the North America glucose monitoring devices market is segmented into fingertip testing and alternate site testing. The fingertip testing segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on end user, the North America glucose monitoring devices market is segmented into healthcare setting and self/homecare. The self/homecare segment held a larger share of the North America glucose monitoring devices market in 2022.

Based on country, the North America glucose monitoring devices market is segmented int o the US, Canada, and Mexico. The US dominated the North America glucose monitoring devices market in 2022.

B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, and GE HealthCare Technologies Inc, and Terumo Corp are some of the leading companies operating in the North America glucose monitoring devices market.

Summary Info

Industry:

Number of pages:

Pricing options:

, ,

Publishing status:

Geographical coverage:

Year of Publication:

At 11.6% CAGR, the North America Glucose Monitoring Devices Market is Speculated to be Worth US$ 14,409.58 million by 2030, saysthe research team

According tothe research team’ research, the North America glucose monitoring devices market was valued at US$ 5,987.78 million in 2022 and is expected to reach US$ 14,409.58 million by 2030, registering a CAGR of 11.6% from 2022 to 2030. Rising incidence of diabetes is a critical factor attributed to the North America glucose monitoring devices market expansion.

Diabetes is a life-threatening chronic disease with no specialized cure. It is mainly caused by the body’s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. There are two types of diabetes—diabetes type-I (also known as diabetes insipidus) and diabetes type-II (also termed diabetes mellitus). The incidence and prevalence of diabetes are steadily increasing across the world. Type 2 diabetes is the most prevalent form of diabetes and has increased alongside cultural and societal changes. In high-income countries, up to 91% of adults with the disease have type 2 diabetes. According to International Diabetes Federation (IDF), approximately 537 million people were living with diabetes in 2022 and is expected to reach 738 million by 2045 globally. Patients suffering from diabetes require frequent monitoring and external administration of insulin. The rising prevalence of diabetes across the globe is driving the growth of the North America glucose monitoring devices market.

On the contrary, high cost of glucose monitoring devices hampers the North America glucose monitoring devices market.

Based on type, the North America glucose monitoring devices market is bifurcated into continuous glucose monitoring devices and self-glucose monitoring devices. The self-glucose monitoring devices held 59.5% share of North America glucose monitoring devices market in 2022, amassing US$ 3,561.70 million. It is projected to garner US$ 8,387.68 million by 2030 to expand at 11.3% CAGR during 2022–2030.

Based on application, the North America glucose monitoring devices market is bifurcated into type 1 diabetes and type 2 diabetes. The type 2 diabetes segment held 69.6% share of North America glucose monitoring devices market in 2022, amassing US$ 4,170.21 million. It is projected to garner US$ 9,949.40 million by 2030 to expand at 11.5% CAGR during 2022–2030.

Based on testing site, the North America glucose monitoring devices market is bifurcated into fingertip testing and alternate site testing. The fingertip testing segment held 70.2% share of North America glucose monitoring devices market in 2022, amassing US$ 4,205.77 million. It is projected to garner US$ 10,403.89 million by 2030 to expand at 12.0% CAGR during 2022–2030.

Based on end user, the North America glucose monitoring devices market is bifurcated into healthcare setting and self/homecare. The self/homecare segment held 66.8% share of North America glucose monitoring devices market in 2022, amassing US$ 3,997.99 million. It is projected to garner US$ 9,335.15 million by 2030 to expand at 11.2% CAGR during 2022–2030.

Based on country, the North America glucose monitoring devices market has been categorized into the US, Canada, and Mexico. Our regional analysis states that the US captured 82.7% share of North America glucose monitoring devices market in 2022. It was assessed at US$ 4,951.02 million in 2022 and is likely to hit US$ 12,135.85 million by 2030, exhibiting a CAGR of 11.9% during 2022–2030.

Key players operating the North America glucose monitoring devices market are B. Braun SE, F. Hoffmann-La Roche Ltd, LifeScan Inc, Medtronic Plc, Abbott Laboratories, Ypsomed Holding AG, Senseonics Holdings Inc, Nipro Corp, GE HealthCare Technologies Inc, and Terumo Corp, among others.

In June-2022, Roche’s Accu-Chek Inform II hospital blood glucose system was approved by Health Canada for intensive care use. The Accu-Chek Inform II solution has brought and continues to bring high-end laboratory standards to bedside glucose testing and helps ensure the safety of patients. In Oct-2022, Life Scan launched OneTouch Solutions, an eCommerce site offering a comprehensive and convenient choice of personalized wellness programs to help people manage diabetes. OneTouch Solutions is available to US consumers and offered to healthcare providers, payors, and employers as a reimbursed adjudicated option.

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific frozen waffles market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– the key findings and recommendations highlight crucial progressive industry trends in Asia Pacific frozen waffles market, thereby allowing players across the value chain to develop effective long-term strategies.
– develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction
1.1 Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Glucose Monitoring Devices Market – Key Industry Dynamics
4.1 Key Market Drivers
4.1.1 Rising Incidence of Diabetes
4.1.2 Growing Geriatric Population
4.1.3 Increasing Prevalence of Obesity
4.2 Key Market Restraints
4.2.1 High Cost of Glucose Monitoring Devices
4.3 Key Market Opportunities
4.3.1 Growing Medical Tourism in Developing Countries
4.4 Future Trends
4.4.1 Rapid Technological Advancements in Glucose Monitoring Devices
5. Glucose Monitoring Devices Market – North America Market Analysis
5.1 North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2022 – 2030
6. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Type
6.1 Overview
6.2 North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
6.3 Continuous Glucose Monitoring Devices
6.3.1 Overview
6.3.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.1 Sensors
6.3.2.1.1 Sensors: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.2 Transmitters
6.3.2.2.1 Transmitters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.3.2.3 Receivers
6.3.2.3.1 Receivers: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Self-Glucose Monitoring Devices
6.4.1 Overview
6.4.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.1 Testing Strips
6.4.2.1.1 Testing Strips: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.2 Glucose Meters
6.4.2.2.1 Glucose Meters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.3 Lancets
6.4.2.3.1 Lancets: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
6.4.2.4 Others
6.4.2.4.1 Others: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Application
7.1 Overview
7.2 North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
7.3 Type 1 Diabetes
7.3.1 Overview
7.3.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Type 2 Diabetes
7.4.1 Overview
7.4.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by Testing Site
8.1 Overview
8.2 North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
8.3 Fingertip Testing
8.3.1 Overview
8.3.2 Fingertip Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Alternate Site Testing
8.4.1 Overview
8.4.2 Alternate Site Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 – by End User
9.1 Overview
9.2 North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
9.3 Healthcare Settings
9.3.1 Overview
9.3.2 Healthcare Settings: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Self/Homecare
9.4.1 Overview
9.4.2 Self/Homecare: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10. North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 –Country Analysis
10.1 North America: Glucose Monitoring Devices Market
10.1.1 Overview
10.1.2 North America: Glucose Monitoring Devices Market , by Country
10.1.2.1 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.1.3 US: North America Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.1.3.1 US: North America Glucose Monitoring Devices Market , by Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.3.2 US: North America Glucose Monitoring Devices Market , by Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.1.4 US: North America Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.1.5 US: North America Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.1.6 US: North America Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.2.3 Canada Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.2.3.1 Canada Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.3.2 Canada Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices, 2020–2030 (US$ Million)
10.1.2.2.4 Canada Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.2.5 Canada Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.2.6 Canada Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
10.1.2.3 Mexico Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
10.1.2.3.3 Mexico Glucose Monitoring Devices Market , by Type, 2020–2030 (US$ Million)
10.1.2.3.3.1 Mexico Glucose Monitoring Devices Market , For Continuous Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.3.2 Mexico Glucose Monitoring Devices Market , For Self-Glucose Monitoring Devices by Type, 2020–2030 (US$ Million)
10.1.2.3.4 Mexico Glucose Monitoring Devices Market , by Application, 2020–2030 (US$ Million)
10.1.2.3.5 Mexico Glucose Monitoring Devices Market , by Testing Site, 2020–2030 (US$ Million)
10.1.2.3.6 Mexico Glucose Monitoring Devices Market , by End User, 2020–2030 (US$ Million)
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the North America North America Glucose Monitoring Devices Market
11.3 Organic Developments
11.3.1 Overview
11.1 Inorganic Developments
11.1.1 Overview
12. Company Profiles
12.1 B. Braun SE
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 F. Hoffmann-La Roche Ltd
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 LifeScan Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Medtronic Plc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Abbott Laboratories
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Ypsomed Holding AG
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Senseonics Holdings Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Nipro Corp
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 GE HealthCare Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Terumo Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America Glucose Monitoring Devices Market Segmentation
Table 2. Prevalence of diabetes worldwide, 2021
Table 3. US Glucose Monitoring Devices Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 4. US Glucose Monitoring Devices Market, by Continuous Glucose Monitoring Devices by Type – Revenue and Forecast to 2030 (US$ Million)
Table 5. US Glucose Monitoring Devices Market, by Self-Glucose Monitoring Devices– Revenue and Forecast to 2030 (US$ Million)
Table 6. US Glucose Monitoring Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 7. US Glucose Monitoring Devices Market, by Testing Site – Revenue and Forecast to 2030 (US$ Million)
Table 8. US Glucose Monitoring Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 9. Canada Monitoring Devices Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 10. Canada Monitoring Devices Market, For Continuous Glucose Monitoring Devices– Revenue and Forecast to 2030 (US$ Million)
Table 11. Canada Monitoring Devices Market, For Self-Glucose Monitoring Devices– Revenue and Forecast to 2030 (US$ Million)
Table 12. Canada Monitoring Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 13. Canada Monitoring Devices Market, by Testing Site – Revenue and Forecast to 2030 (US$ Million)
Table 14. Canada Monitoring Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 15. Mexico North America Glucose Monitoring Devices Market, by Type – Revenue and Forecast to 2030 (US$ Million)
Table 16. Mexico North America Glucose Monitoring Devices Market, For Continuous Glucose Monitoring Devices by Type – Revenue and Forecast to 2030 (US$ Million)
Table 17. Mexico North America Glucose Monitoring Devices Market, For Self-Glucose Monitoring Devices by Type – Revenue and Forecast to 2030 (US$ Million)
Table 18. Mexico North America Glucose Monitoring Devices Market, by Application – Revenue and Forecast to 2030 (US$ Million)
Table 19. Mexico North America Glucose Monitoring Devices Market, by Testing Site – Revenue and Forecast to 2030 (US$ Million)
Table 20. Mexico North America Glucose Monitoring Devices Market, by End User – Revenue and Forecast to 2030 (US$ Million)
Table 21. Organic Developments Done by Companies
Table 22. Inorganic Developments Done by Companies
Table 23. Glossary of Terms, North America North America Glucose Monitoring Devices Market

LIST OF FIGURES

Figure 1. North America Glucose Monitoring Devices Market Segmentation, By Country
Figure 2. North America North America Glucose Monitoring Devices Market: Key Industry Dynamics
Figure 3. North America North America Glucose Monitoring Devices Market: Impact Analysis of Drivers and Restraints
Figure 4. North America Glucose Monitoring Devices Market Revenue (US$ Mn), 2020 – 2030
Figure 5. North America Glucose Monitoring Devices Market Revenue Share, by Type 2022 & 2030 (%)
Figure 6. Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Sensors: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Transmitters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Receivers: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Testing Strips: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Glucose Meters: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Lancets: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. North America Glucose Monitoring Devices Market Revenue Share, by Application 2022 & 2030 (%)
Figure 16. Type 1 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. North America Glucose Monitoring Devices Market Revenue Share, by Testing Site 2022 & 2030 (%)
Figure 19. Fingertip Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Alternate Site Testing: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. North America Glucose Monitoring Devices Market Revenue Share, by End User 2022 & 2030 (%)
Figure 22. Healthcare Settings: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 23. Self/Homecare: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 24. North America: North America North America Glucose Monitoring Devices Market, by Key Country – Revenue (2022) (US$ Million)
Figure 25. North America: North America North America Glucose Monitoring Devices Market, by Country, 2022 & 2030 (%)
Figure 26. US: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 27. Canada: Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 28. Mexico Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
Figure 29. Growth Strategies in the North America North America Glucose Monitoring Devices Market

The List of Companies – North America Glucose Monitoring Devices Market

– B. Braun SE
– F. Hoffmann-La Roche Ltd
– LifeScan Inc
– Medtronic Plc
– Abbott Laboratories
– Ypsomed Holding AG
– Senseonics Holdings Inc
– Nipro Corp
– GE HealthCare Technologies Inc
– Terumo Corp

Reviews

There are no reviews yet.

Be the first to review “North America Glucose Monitoring Devices Market Forecast to 2030”